Skip Navigation
Search site

We are building you a better website. You might be interested to see the new look here, and let us know what you think.

Female Genital Mutilation (FGM) - January 2016 to March 2016, Experimental Statistics Report

23:26 June 22, 2017 - 09:30 June 07, 2016
Publication date: June 07, 2016
Return to Find data

Summary

The Female Genital Mutilation (FGM) Enhanced Dataset (SCCI 2026) is a repository for individual level data collected by healthcare providers in England, including acute hospital providers, mental health providers and GP practices

Key facts

The Female Genital Mutilation (FGM) Enhanced Dataset (SCCI 2026) is a repository for individual level data collected by healthcare providers in England, including acute hospital providers, mental health providers and GP practices.

All figures reported below relate to national level English data for attendances during the quarter January to March 2016

Caution is advised throughout any interpretation of these findings because data completeness is often low and varies by commissioning region and submitter.

  • 81 NHS trusts and 12 GP practices submitted one or more FGM attendance record. Submission is mandatory for NHS acute and mental health trusts and GP practices.
  • Almost all the information was submitted by NHS trusts. GP practices submitted just 2 per cent of newly recorded women and girls and 1 per cent of total attendances.
  •  There were 1,242 newly recorded cases of FGM reported, with 2,223 total attendances where FGM was identified or a procedure for FGM was undertaken.
  • More than half of all cases relate to women and girls from London NHS Commissioning Region: 52 per cent of newly recorded cases and 60 per cent of total attendances
  • GP practices and NHS organisations were the most frequent type of referring organisations, accounting for 45 and 46 per cent of cases where FGM was reported.
  • Where the FGM Type is known, Types 1 and 2 have the highest incidence (38 and 30 per cent respectively).
  • In combination, Types 1, 2 and 3 covered 90 per cent of known FGM Types, with a relatively low incidence of the remaining categories.
  • 29 girls under 18 at the time of their first attendance were reported, comprising 2 per cent of all newly recorded cases.
  • Self-report was the most frequent method of FGM identification, accounting for 75 per cent of cases where the FGM identification method was known.
  • 88 per cent of women and girls with a known country of birth were born in an Eastern, Northern or Western African country.
  •  8 per cent of women and girls with a known country of birth were born in Asia (the majority from Western Asian countries, Iraq and the Yemen).
  •  Somalia in Eastern Africa accounts for more than one third of all newly recorded women and girls with a known country of birth. Other countries with a large volume of cases include Eritrea in Eastern Africa, the Sudan in Northern Africa and Nigeria in Western Africa.
  • 11 newly recorded cases of FGM involved women and girls reported to have been born in the United Kingdom.
  • 84 per cent of women and girls with a known pregnancy status were pregnant at the point of attendance.
  • 19 deinfibulation procedures were reported, occurring at 2 per cent of attendances where deinfibulation status was recorded.

Definitions

1 Newly Recorded women and girls with FGM are those who have had their FGM information collected in the FGM Enhanced Dataset for the first time. This will include those identified as having FGM and those having treatment for their FGM.

 

‘Newly recorded’ does not necessarily mean that the attendance is the woman or girl’s first attendance for FGM.

2 Total Attendances refers to all attendances in the reporting period where FGM was identified or a procedure for FGM was undertaken. Women and girls may have one or more attendances in the reporting period. This category includes both newly recorded and previously identified women and girls.

Resources

Coverage

Date Range: January 01, 2016 to March 31, 2016
Geographical coverage:
England
Geographical granularity:
Regions
Clinical Commissioning Groups

Related links

Return to Find data
Close iCM Form